Seeking Alpha

Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan

RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the clinical research industry-leading Metasite™, today announced that it has been honored with the ...
FierceBiotech

Science 37 Secures $6.5M Series A Funding To Accelerate Clinical Trial Research

Science 37's new metasiteTM operating model efficiently delivers end-to-end clinical trial services under a single contract by leveraging partnerships with national mobile nursing companies, pharmacy ...
Nasdaq

Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment

RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading MetasiteTM, today ...
Yahoo Finance

Science 37 Launches Dedicated Pediatrics Department to Expand Access to Specialized Clinical Research for Children and Families

MORRISVILLE, N.C., March 17, 2026 (GLOBE NEWSWIRE)-- Science 37, the leader in expanding patient access to clinical trials, today announced the formal launch of its dedicated Pediatrics Department, ...
Seeking Alpha

Science 37 Adds New Head of Quality, Irena Lambridis

RESEARCH TRIANGLE PARK, N.C., April 18, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the industry-leading Metasite™, today announced the appointment of Irena Lambridis as its Global Head ...
FierceBiotech

Science 37 tapped for Synlogic's phase 3 trial of potential PKU treatment

Science 37 has been tapped to use its virtual clinical trial tech for phase 3 trials of Synlogic’s treatment for the rare genetic metabolic disorder phenylketonuria (PKU). Under the deal, Science 37’s ...
Nasdaq

Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future

Transaction values Science 37 at an enterprise value of approximately $1.05 billion at closing Positions Science 37 with a balance sheet of up to $250 million to fund its decentralized trial ...
Yahoo Finance

Science 37 Appoints Kelly Johnston McKee as VP of Strategy & Transformation

MORRISVILLE, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, today announced the appointment of Kelly Johnston McKee as Vice President, ...
Business Wire

Science 37 Raises $29M to Bring Clinical Trials Directly into Patients’ Homes

PLAYA VISTA, Calif.--(BUSINESS WIRE)--Science 37, a trailblazing company focused on “site-less” clinical trials, announced today $29 million in Series C funding led by Glynn Capital Management with ...
Business Wire

Science 37® and Foundation Medicine Partner to Enable Interventional Home-Based Clinical Trials in Oncology

LOS ANGELES & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Science 37 and Foundation Medicine today announced a collaboration to enable decentralized clinical research in oncology that will optimize recruitment ...
Los Angeles Business Journal

Science 37 Plans to Go Public in $1.33 Billion Deal

37 Medical Director Christopher Reist using the company’s platform. Playa Vista-based Science 37 Inc., a digital clinical trial firm, is becoming a publicly listed company through a merger with ...
Business Insider

Science 37, a virtual-trials startup once eyed by Alphabet's Verily, just raised $40 million to push the drug industry decades into the future

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. It's been a busy year for Science 37, a Los Angeles startup that brings clinical trials online. Top ...